GWS
PFE icon

Greykasell Wealth Strategies’s Pfizer PFE Stock Holding History

Greykasell Wealth Strategies’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.8K Hold
1,310
– – 0.01% 270
2025
Q4 		$32.6K Sell
1,310
-545
-29% -$13.7K 0.01% 272
2025
Q3 		$47.3K Sell
1,855
-1,939
-51% -$47.9K 0.02% 208
2025
Q2 		$92K Buy
3,794
+1,005
+36% +$23.4K 0.04% 164
2025
Q1 		$70.7K Buy
+2,789
New +$73K 0.04% 165

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Greykasell Wealth Strategies's PFE Position: Q1 2026 in Review

Greykasell Wealth Strategies held its Pfizer (PFE) position steady in Q1 2026 at 1,310 shares worth $36.8K. The position accounts for 0.01% of the portfolio, ranked #270.

Greykasell Wealth Strategies first reported a position in PFE in Q1 2025 and has held it in 5 quarters since. The position peaked at $92K in Q2 2025. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Greykasell Wealth Strategies held 1,310 shares of Pfizer worth $36.8K as of Q1 2026.
  • Greykasell Wealth Strategies left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.01% of Greykasell Wealth Strategies's portfolio in Q1 2026, its #270 holding.
  • Greykasell Wealth Strategies first reported a position in Pfizer in Q1 2025 and has held it in 5 quarters since.
  • Greykasell Wealth Strategies's Pfizer position peaked at $92K in Q2 2025.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Greykasell Wealth Strategies's 13F filing for Q1 2026, filed 7 May 2026.